Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Apr. 28, 2024	Apr. 30, 2023
Cash flows from operating activities:
Net income	$ 95,454	$ 88,223
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	41,487	39,085
Share-based compensation	6,499	3,830
Changes in assets and liabilities:
Accounts receivable	(2,415)	(5,952)
Inventories	(4,407)	(1,905)
Other current assets	(4,340)	1,382
Accounts payable, accrued liabilities, and other	(14,284)	(14,986)
Net cash provided by operating activities	117,994	109,677
Cash flows from investing activities:
Purchases of property, plant and equipment	(63,311)	(57,728)
Purchases of short-term investments	(66,040)	(9,837)
Proceeds from maturities of short-term investments	13,234	4,000
Government incentives	1,419	1,393
Other	(6)	(88)
Net cash used in investing activities	(114,704)	(62,260)
Cash flows from financing activities:
Repayments of debt	(2,844)	(14,720)
Proceeds from share-based arrangements	1,055	730
Net settlements of restricted stock awards	(2,938)	(1,252)
Net cash used in financing activities	(4,727)	(15,242)
Effects of exchange rate changes on cash, cash equivalents, and restricted cash	(3,839)	15,621
Net increase (decrease) in cash, cash equivalents, and restricted cash	(5,276)	47,796
Cash, cash equivalents, and restricted cash at beginning of period	501,867	322,409
Cash, cash equivalents, and restricted cash at end of period	496,591	370,205
Less: Ending restricted cash	2,686	2,720
Cash and cash equivalents at end of period	493,905	367,485
Supplemental disclosure of non-cash information:
Accruals for property, plant and equipment purchased during the period	$ 7,871	$ 14,420